DrugPatentWatch Database Preview
ULTRAM Drug Profile
Which patents cover Ultram, and what generic alternatives are available?
Ultram is a drug marketed by Janssen Pharms and Valeant Pharms and is included in two NDAs. There is one patent protecting this drug and three Paragraph IV challenges.
The generic ingredient in ULTRAM is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.
Summary for ULTRAM
| US Patents: | 1 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 15 |
| Clinical Trials: | 17 |
| Patent Applications: | 122 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ULTRAM |
| DailyMed Link: | ULTRAM at DailyMed |
Pharmacology for ULTRAM
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for ULTRAM
Synonyms for ULTRAM
| (-)-2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)CYCLOHEXANOL |
| (1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclo-hexanol |
| (1RS,2RS)-2-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexanol |
| 1-(m-Methoxyphenyl)-2-(dimethylaminomethyl)cyclohexane-1-ol |
| 2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexan-1-ol |
| 2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexan-1-ol |
| 2-[ methyl]-1- cyclohexan-1-ol |
| 2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)CYCLOHEXAN-1-OL |
| 2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol |
| 2-Dimethylaminomethyl-1-(m-methoxyphenyl)cyclohexanol |
| 2914-77-4 |
| 3B1-000741 |
| AC1L1KJ8 |
| AC1Q7AST |
| ACM2914774 |
| AKOS022507395 |
| AN-32783 |
| CHEBI:75722 |
| CHEMBL1237044 |
| ConZip |
| COR0000099 |
| CTK4G2807 |
| Cyclohexanol, 2-(dimethylaminomethyl)-1-(m-methoxyphenyl)- |
| Cyclohexanol, 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)- |
| Cyclohexanol,2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)- |
| D05GKD |
| EINECS 220-831-4 |
| GTPL8286 |
| L000985 |
| LS-57112 |
| LS-57113 |
| LS-57114 |
| Maxitram |
| MCULE-1882520267 |
| OR009034 |
| OR148688 |
| OR148689 |
| Rybix ODT |
| Ryzolt |
| SCHEMBL57496 |
| Tilodol |
| TVYLLZQTGLZFBW-UHFFFAOYSA-N |
US Patents and Regulatory Information for ULTRAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | ULTRAM | tramadol hydrochloride | TABLET;ORAL | 020281-002 | Mar 3, 1995 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Valeant Pharms | ULTRAM ER | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021692-002 | Sep 8, 2005 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Janssen Pharms | ULTRAM | tramadol hydrochloride | TABLET;ORAL | 020281-001 | Mar 3, 1995 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Valeant Pharms | ULTRAM ER | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021692-001 | Sep 8, 2005 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Valeant Pharms | ULTRAM ER | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021692-003 | Sep 8, 2005 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ULTRAM
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 300 mg | ➤ Subscribe | ➤ Sign Up |
| ➤ Subscribe | Extended-release Tablets | 200 mg | ➤ Subscribe | ➤ Sign Up |
| ➤ Subscribe | Extended-release Tablets | 100 mg | ➤ Subscribe | ➤ Sign Up |
